April 29 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday published the final rule to ensure safety and effectiveness of laboratory developed tests (LDTs), which are designed, manufactured and used within a clinical laboratory. (Reporting by Mariam Sunny in Bengaluru; Editing by Shinjini Ganguli)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
205.3 USD | -0.72% | -2.77% | -9.66% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
205.3 USD | -0.72% | -2.77% | 17.43B | ||
143.3 USD | -0.58% | +3.00% | 16.02B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.66% | 17.43B | |
+18.63% | 85.14B | |
-27.41% | 72.06B | |
+2.75% | 27.07B | |
-1.96% | 16.98B | |
+3.96% | 16.02B | |
+7.75% | 13.87B | |
+72.83% | 13.06B | |
+72.50% | 12.79B | |
+32.39% | 12.36B |
- Stock Market
- Equities
- LH Stock
- News Labcorp Holdings Inc.
- US FDA publishes final rule for laboratory developed tests